Yong-Seop Park

Title: Yong-Seop Park: Innovator in Ophthalmic Pharmaceutical Composition

Introduction

Yong-Seop Park is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of ophthalmic pharmaceuticals. His innovative work focuses on improving the stability and efficacy of pharmaceutical compositions.

Latest Patents

Yong-Seop Park holds a patent for an ophthalmic pharmaceutical composition that includes aflibercept as an active ingredient. This composition is designed to maintain a specific pH and incorporates an acetate salt buffering agent. Notably, it is free of ionic tonicity agents, which helps to remarkably reduce the formation of dimeric and multimeric impurities. The composition also ensures that biological activity remains high over extended periods, even under accelerated stress conditions and cold storage.

Career Highlights

Yong-Seop Park is associated with Sam Chun Dang Pharm. Co., Ltd., where he continues to develop innovative pharmaceutical solutions. His work has been instrumental in advancing the field of ophthalmology, particularly in the formulation of effective treatments.

Collaborations

Yong-Seop Park has collaborated with esteemed colleagues such as Guang-Jin Im and Byung-Jhip Ha. Their combined expertise contributes to the ongoing success of their projects and innovations.

Conclusion

Yong-Seop Park's contributions to ophthalmic pharmaceuticals exemplify the impact of innovation in healthcare. His patent for an aflibercept ophthalmic pharmaceutical composition showcases his commitment to enhancing treatment efficacy and stability.